Skip to main content
Top
Published in: Internal and Emergency Medicine 1/2020

01-01-2020 | Hypercalcemia | IM - REVIEW

Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?

Authors: Claudia Fofi, Barbara Maresca, Silvia Altieri, Paolo Menè, Francescaromana Festuccia

Published in: Internal and Emergency Medicine | Issue 1/2020

Login to get access

Abstract

Addison disease is due to the destruction or dysfunction of the entire adrenal cortex. Nowadays, the causes of adrenal insufficiency are autoimmune disease for 70–90% and tuberculosis for 7–20%. Many typical signs and symptoms, such as hyponatremia, hyperkalaemia, or renal insufficiency can represent the reasons for a nephrology consultation, especially in conditions of urgency, and they can easily be confused with other causes. Moreover, the fact that in a short time range we have diagnosed the three cases described as a guide in this review, has aroused our attention as nephrologists on a disease in which we have probably already encountered but without recognizing it. The blood tests showed in all three patients severe electrolyte disorders and acute renal failure which will be discussed in their physiopathogenetic mechanisms. In a peculiar way, these alterations were not controlled with repolarizing solutions, fluid replacement and increased volemia, but only after steroid administration. In conclusion, in this review all the known pathogenic mechanisms causing disorders of nephrological interest in adrenal insufficiency are discussed.
Literature
1.
go back to reference Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. Highley, London Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. Highley, London
2.
go back to reference Irvine WJ, Barnes EW (1972) Adrenocortical insufficiency. Clin Endocrinol Metab 1:549 Irvine WJ, Barnes EW (1972) Adrenocortical insufficiency. Clin Endocrinol Metab 1:549
3.
go back to reference Zelissen PM, Bast EJ, Croughs RJ (1995) Associated autoimmunity in Addison's disease. J Autoimmun 8:121–130PubMed Zelissen PM, Bast EJ, Croughs RJ (1995) Associated autoimmunity in Addison's disease. J Autoimmun 8:121–130PubMed
4.
go back to reference Kasperlik-Zaluska AA, Migdalska B, Czarnocka B et al (1991) Association of Addison's disease with autoimmune disorders—a long-term observation of 180 patients. Postgrad Med J 67:984–987PubMedPubMedCentral Kasperlik-Zaluska AA, Migdalska B, Czarnocka B et al (1991) Association of Addison's disease with autoimmune disorders—a long-term observation of 180 patients. Postgrad Med J 67:984–987PubMedPubMedCentral
5.
go back to reference Moreira AC, Martinez R, Castro M, Elias LL (1992) Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests. Clin Endocrinol 36:545–551 Moreira AC, Martinez R, Castro M, Elias LL (1992) Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests. Clin Endocrinol 36:545–551
6.
go back to reference Nomura K, Demura H, Saruta T (1994) Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Intern Med 33:602–606PubMed Nomura K, Demura H, Saruta T (1994) Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Intern Med 33:602–606PubMed
8.
go back to reference Laureti S, Vecchi L, Santeusanio F, Falorni A (1999) Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 84:1762PubMed Laureti S, Vecchi L, Santeusanio F, Falorni A (1999) Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 84:1762PubMed
9.
go back to reference Erichsen MM, Lovas K, Skinnisqrud B et al (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882–4890PubMed Erichsen MM, Lovas K, Skinnisqrud B et al (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882–4890PubMed
10.
go back to reference Cutolo M (2014) Autoimmune polyendocrine syndrome Auitoimmun Rev 13:85–89 Cutolo M (2014) Autoimmune polyendocrine syndrome Auitoimmun Rev 13:85–89
11.
go back to reference Brandao Neto RA, De Carvalho JF (2014) Diagnosis and classification of Addison’s disease (autoimmune adrenalitis). Autoimmun Rev 13:408–411PubMed Brandao Neto RA, De Carvalho JF (2014) Diagnosis and classification of Addison’s disease (autoimmune adrenalitis). Autoimmun Rev 13:408–411PubMed
12.
go back to reference Olafsson AS, Sigurjonsdottir HA (2016) Increasing prevalence of Addoson disease: results from a nationwidw study. Endocr Pract 22:30–35PubMed Olafsson AS, Sigurjonsdottir HA (2016) Increasing prevalence of Addoson disease: results from a nationwidw study. Endocr Pract 22:30–35PubMed
13.
go back to reference Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndrome: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364PubMed Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndrome: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364PubMed
14.
go back to reference Lombardi M, Michelassi S, Betterle C (2013) Conoscerlo per riconoscerlo: morbo di Addison con sindrome poliendocrina autoimmune di tipo II. Giornale di Tecniche Nefrologiche e Dialitiche 25:37–42 Lombardi M, Michelassi S, Betterle C (2013) Conoscerlo per riconoscerlo: morbo di Addison con sindrome poliendocrina autoimmune di tipo II. Giornale di Tecniche Nefrologiche e Dialitiche 25:37–42
15.
go back to reference Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853PubMed Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853PubMed
16.
go back to reference Muls E, Bouillon R, Boelaert J et al (1982) Etiology of hypercalcemia in a patient with Addison’s desease. Calcif Tissue Int 34:523–526PubMed Muls E, Bouillon R, Boelaert J et al (1982) Etiology of hypercalcemia in a patient with Addison’s desease. Calcif Tissue Int 34:523–526PubMed
17.
go back to reference Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893PubMed Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893PubMed
18.
go back to reference Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:364–389PubMed Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:364–389PubMed
19.
go back to reference Lau SY, Yong TY (2012) Rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatremia. Intern Med 51:2371–2374PubMed Lau SY, Yong TY (2012) Rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatremia. Intern Med 51:2371–2374PubMed
20.
go back to reference Maguet H, Carreau A, Hautefeuille S et al (2017) An Addison disease revealed with a serious hyponatremia. Ann Biol Clin 75:87–91 Maguet H, Carreau A, Hautefeuille S et al (2017) An Addison disease revealed with a serious hyponatremia. Ann Biol Clin 75:87–91
21.
go back to reference Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321:492–496PubMed Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321:492–496PubMed
22.
go back to reference Ishikawa S, Schrier RW (1982) Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int 22:587–593PubMed Ishikawa S, Schrier RW (1982) Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int 22:587–593PubMed
23.
go back to reference Kamoi K, Tamura T, Tanaka K et al (1993) Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab 77:1584–1588PubMed Kamoi K, Tamura T, Tanaka K et al (1993) Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab 77:1584–1588PubMed
25.
go back to reference Correia F, Fernandes A, Mota TC et al (2015) Hyponatremia in a teenager: a rare diagnosis. Pediatr Emerg Care 31:860–863PubMed Correia F, Fernandes A, Mota TC et al (2015) Hyponatremia in a teenager: a rare diagnosis. Pediatr Emerg Care 31:860–863PubMed
26.
go back to reference Waise A, Young RJ (1989) Pitfalls in the management of acute adrenocortical insufficiency: discussion paper. J R Soc Med 82:741–742PubMedPubMedCentral Waise A, Young RJ (1989) Pitfalls in the management of acute adrenocortical insufficiency: discussion paper. J R Soc Med 82:741–742PubMedPubMedCentral
27.
go back to reference Connor A, Care S, Taylor J (2010) Addison’s disease presenting with acute kidney injury. Clin Med 10:15–16 Connor A, Care S, Taylor J (2010) Addison’s disease presenting with acute kidney injury. Clin Med 10:15–16
28.
go back to reference Thompson MD, Kalmar E, Bowden SA (2015) Severe hyponatremia with absence of hyperkalaemia in rapidly progressive Addison’s disease. BMJ Case Rep. doi: https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr-2015–209903 Thompson MD, Kalmar E, Bowden SA (2015) Severe hyponatremia with absence of hyperkalaemia in rapidly progressive Addison’s disease. BMJ Case Rep. doi: https://​mc.​manuscriptcentra​l.​com/​bmjcasereports10​.​1136/​bcr-2015–209903
29.
go back to reference Fraser R (1984) Disorders of the adrenal cortex: their effects on electrolyte metabolism. Clin Endocrinol Metab 13:413–430PubMed Fraser R (1984) Disorders of the adrenal cortex: their effects on electrolyte metabolism. Clin Endocrinol Metab 13:413–430PubMed
30.
go back to reference Talbott JH, Pecora LJ, Melville RS, Consolazio WV (1942) Renal function in patients with Addison’s disease and in patients with adrenal insufficiency secondary to pituitary pan-hypofunction. J Clin Invest 21:107–119PubMedPubMedCentral Talbott JH, Pecora LJ, Melville RS, Consolazio WV (1942) Renal function in patients with Addison’s disease and in patients with adrenal insufficiency secondary to pituitary pan-hypofunction. J Clin Invest 21:107–119PubMedPubMedCentral
31.
go back to reference Harvey TC (2007) Addison’s disease and the regulation of potassium: the role of insulin and aldosterone. Med Hypotheses 69:1120–1126PubMed Harvey TC (2007) Addison’s disease and the regulation of potassium: the role of insulin and aldosterone. Med Hypotheses 69:1120–1126PubMed
32.
go back to reference Maki S, Kramarz C, Heister MP, Pasha K. (2016) First presentation of Addison’s disease as hyperkalemia in acute kidney injury. BMJ Case Rep. doi: https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr-2015-213375 Maki S, Kramarz C, Heister MP, Pasha K. (2016) First presentation of Addison’s disease as hyperkalemia in acute kidney injury. BMJ Case Rep. doi: https://​mc.​manuscriptcentra​l.​com/​bmjcasereports10​.​1136/​bcr-2015-213375
33.
go back to reference Siengler DI (1970) Idiopatic Addison’s disease presenting with hypercalcemia. Br Med J 2:522 Siengler DI (1970) Idiopatic Addison’s disease presenting with hypercalcemia. Br Med J 2:522
34.
go back to reference Diamond T, Thornley S (1994) Addisonian crisis and hypercalcemia. Aust N Z J med 24:316PubMed Diamond T, Thornley S (1994) Addisonian crisis and hypercalcemia. Aust N Z J med 24:316PubMed
35.
go back to reference Montoli A, Colussi G, Minetti L (1992) Hypercalcemia in Addison’s disease: calciotropic hormone profile and bone hystology. J Intern Med 232:535–540PubMed Montoli A, Colussi G, Minetti L (1992) Hypercalcemia in Addison’s disease: calciotropic hormone profile and bone hystology. J Intern Med 232:535–540PubMed
36.
go back to reference Miell J, Wassif W, McGregor A et al (1991) Life-threatening hypercalcaemia in association with Addisonian crisis. Postgrad Med J 67:770–772PubMedPubMedCentral Miell J, Wassif W, McGregor A et al (1991) Life-threatening hypercalcaemia in association with Addisonian crisis. Postgrad Med J 67:770–772PubMedPubMedCentral
37.
go back to reference Yamamoto S, Okada Y, Arao T, Tanaka Y (2015) Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case report. J UOEH 37:55–60PubMed Yamamoto S, Okada Y, Arao T, Tanaka Y (2015) Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case report. J UOEH 37:55–60PubMed
38.
go back to reference Walser M, Robinson BH, Duckett JW (1963) The hypercalcemia of adrenal insufficiency. J Clin Inv 42:456–465 Walser M, Robinson BH, Duckett JW (1963) The hypercalcemia of adrenal insufficiency. J Clin Inv 42:456–465
39.
go back to reference Guleke P (1911) Experimentelle untersuchungen uber tetanic. Langenbecks Arch Klin Chir 94:496 Guleke P (1911) Experimentelle untersuchungen uber tetanic. Langenbecks Arch Klin Chir 94:496
40.
go back to reference Loeb RF (1932) Chemical changes in the blood in Addison’s disease. Science 76:420PubMed Loeb RF (1932) Chemical changes in the blood in Addison’s disease. Science 76:420PubMed
41.
go back to reference Downie WW, Gunn A, Paterson CR, Howie GF (1977) Hypercalcemic crisis as presentation of Addison’s disease. Br Med J 1:145–146PubMedPubMedCentral Downie WW, Gunn A, Paterson CR, Howie GF (1977) Hypercalcemic crisis as presentation of Addison’s disease. Br Med J 1:145–146PubMedPubMedCentral
42.
go back to reference Quinkler M, Ekman B, Zhang P (2018) EU-AIR Investigators. Mortality data from the European Adrenal Insufficiency Registry – Patient characterization and associations. Clin Endocr 89:30–35PubMed Quinkler M, Ekman B, Zhang P (2018) EU-AIR Investigators. Mortality data from the European Adrenal Insufficiency Registry – Patient characterization and associations. Clin Endocr 89:30–35PubMed
44.
go back to reference Anglin RE, Rosebush PI, Mazurek MF (2006) The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci 18:450–459PubMed Anglin RE, Rosebush PI, Mazurek MF (2006) The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci 18:450–459PubMed
Metadata
Title
Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?
Authors
Claudia Fofi
Barbara Maresca
Silvia Altieri
Paolo Menè
Francescaromana Festuccia
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02209-x

Other articles of this Issue 1/2020

Internal and Emergency Medicine 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.